GLP-1 RAs were associated with positive effects on intracranial hypertension management, including reduced symptoms and treatment burden.

Intracranial hypertension (IH), a clinical condition typically seen in the intensive care unit, is caused by increased pressure surrounding the brain. In many situations, the cause of chronic IH is ...

The incidence of idiopathic intracranial hypertension (IIH) — characterized by increased cerebral spinal fluid (CSF) pressure — is rising considerably, corresponding to population increases in body ...

Among women with idiopathic intracranial hypertension (IIH) and a body mass index (BMI) of 35 or higher, bariatric surgery was a more effective means of reducing intracranial pressure and sustaining ...

Patients with systemic lupus erythematosus (SLE) with refractory headache warrant further evaluation—particularly if they are children—in order to rule out treatable ailments such as intracranial ...

WOMAN’S DOCTOR. NO ONE LIKES HAVING A HEADACHE THAT JUST DOESN’T GO AWAY. IT’S JUST THERE FOREVER. BUT ADD VISION ISSUES INTO THE EQUATION AND IT CAN BE REALLY TERRIFYING. THESE ARE SOME OF THE ...

AUSTIN, Texas — Venous manometry and neuroimaging may provide additional value when diagnosing patients who do not meet criteria for idiopathic intracranial hypertension, according to a poster ...

Exenatide, a glucagon-like peptide-1 (GLP-1) receptor agonist used to treat type 2 diabetes, may be a potential treatment for idiopathic intracranial hypertension (IIH). In a small phase 2 trial, ...

Please provide your email address to receive an email when new articles are posted on . Young people with intracranial hypertension had an increased prevalence of disordered eating behaviors, ...